There are 2949 resources available
888MO - Effectiveness of brentuximab vedotin in relapsed/refractory classic Hodgkin lymphoma: A systematic review and meta-analysis
Presenter: Bastian von Tresckow
Session: Mini Oral - Haematological malignancies
Resources:
Abstract
Slides
Webcast
889MO - Long-term follow-up of patients with nodular lymphocyte predominant Hodgkin lymphoma: A report from the Spanish Lymphoma Oncology Group
Presenter: Beatriz Nunez Garcia
Session: Mini Oral - Haematological malignancies
Resources:
Abstract
Slides
Webcast
LBA37 - A blinded, randomized, parallel group, comparative investigation of a novel device (Cooral) for cryoprevention of oral mucositis
Presenter: Java Walladbegi
Session: Mini Oral - Haematological malignancies
Resources:
Abstract
Slides
Webcast
890MO - Phase I Alexander study of AUTO3, the first CD19/22 dual targeting CAR.T cell, with pembrolizumab in patients with relapsed/refractory (r/r) DLBCL
Presenter: Eleni Tholouli
Session: Mini Oral - Haematological malignancies
Resources:
Abstract
Slides
Webcast
891MO - Role of baseline PET SUVmax in predicting early progression in follicular lymphoma (FL): A single-center retrospective analysis
Presenter: Ayushi Chauhan
Session: Mini Oral - Haematological malignancies
Resources:
Abstract
Slides
Webcast
892MO - High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with HIV-related lymphoma
Presenter: Marina Popova
Session: Mini Oral - Haematological malignancies
Resources:
Abstract
Slides
Webcast
893MO - An open-label, single-center, phase II, single-arm trial of camrelizumab combined with apatinib in patients with relapsed or refractory peripheral T-cell lymphoma
Presenter: Yan Xie
Session: Mini Oral - Haematological malignancies
Resources:
Abstract
Slides
Webcast
912MO - A single-arm, open-label, multicenter phase II study of camrelizumab in patients with recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC) who had progressed on ≥2 lines of chemotherapy: CAPTAIN study
Presenter: Li Zhang
Session: Mini Oral - Head & neck cancer
Resources:
Abstract
Slides
Webcast
913MO - Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma in Hong Kong (2001-2010): A territory-wide study by HKNPCSG
Presenter: James Chow
Session: Mini Oral - Head & neck cancer
Resources:
Abstract
Slides
Webcast
914MO - Standard versus fractionated high dose cisplatin concomitant with radiotherapy in locally advanced head & neck squamous cell cancer (LA-HNSCC): Results of the GORTEC 2015-02 CisFRad randomized trial
Presenter: Christian Borel
Session: Mini Oral - Head & neck cancer
Resources:
Abstract
Slides
Webcast